CLINICAL ROLE -
Complex Molecule Modifications May Enhance Cancer Drugs
New research may transform oncology drug development.
Read More
Spending Bill May Interfere With Evidence-Based Mammagrapy Recommendations
Researchers warn political interference may discourage shared decision-making in breast cancer treatment.
New Technique Allows for Less Chemotherapy Without Loss of Efficacy in Lung Cancer
Use of exomes shield lung cancer drug from immune system defenses.
First Sub-Licences Signed for Hepatitis C Drug Daclatasvir
HCV treatment has been shown to cure up to 100% of patients depending on genotype and stage of liver disease.
Hepatitis B Treatment Market to Experience Modest Growth
Global therapeutics market for chronic hepatitis B virus projected to rise from $2.4 billion to $3 billion by 2024.
FDA Grants Chronic Lymphocytic Leukemia Drug Priority Review
Venetoclax is a B-cell lymphoma-2 protein inhibitor for the treatment of CLL patients who received a least one prior therapy.
Beyond the Ice Bucket Challenge: Patients Fight for New ALS Therapies
A young Navy veteran finds hope in his struggle with amyotrophic lateral sclerosis, as the hunt for a cure continues.
Chemotherapy Can Remain Useful After Targeted Therapy in Cancer Treatment
Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.
Component in Cotton Could Halt Prostate Cancer Development
Byproduct found in cotton plant rid the body of abnormal cancerous cells.
Merck Settles Class Action Lawsuit Regarding Vioxx
Merck required to pay $830 million in damage recovery related to discontinued arthritis drug.
Chemo Can Remain Useful After Targeted Therapy in Cancer Treatment
Genetic Changes in Breast Cancer May Lead to New Targeted Therapies
Researchers examine how genetic changes in breast cancer cells interfere with pathways critical to disease growth and survival.
Proposed Changes to Medicare Advantage Would Change Payments Based on Geography
Study seeks to address underpayments received by low-income Medicare beneficiaries or dual eligibles.
Can Information from Online Health Forums be Trusted?
Research examines accuracy of health care information on discussion board web sites Reddit, Mumsnet, and Patient.
FDA Approves Arzerra for Extended Treatment of CLL
Arzerra found to nearly double progression-free survival in chronic lymphocytic leukemia compared with observation.
Diabetes Drug Found to Inhibit Pancreatic Cancer Progression
Metformin decreased inflammation and scarring observed in more common pancreatic cancers.
Common Painkiller Shows Cancer-Fighting Properties
Combination of diclofenac with chemotherapy and radiation may greatly improve treatment of cancer patients.
Study Finds No Additional Benefit from Multiple Myeloma Drug
Pomalyst was approved in 2013 for use in combination with dexamethasone to inhibit tumor growth.
Sanders Releases Plan for Universal Single-Payer Health Care System
Controversial proposal would essentially do away with copayments and deductibles.
FDA Approves Cosentyx for Ankylosing Spondylitis, Psoriatic Arthritis
Cosentyx was previously approved for the treatment of moderate-to-severe plaque psoriasis.
Controversial proposal would essentially replace health care plans Americans currently obtain via their employers or purchased individually.
Should Parental Permission be Required for Adolescents to Participate in HIV Research?
Few state minor-consent laws authorize participation in clinical trials and therapies.
Potential Target Found for Triple-Negative Breast Cancer Treatment
Research examines long non-coding RNAs as biomarkers and therapeutic targets.
Protein Kinase Family May Offer Cancer Drug Target
PKN proteins are gaining recognition as drug targets for cancer research.
Vice President Biden Announces Widespread Initiative to Fight Cancer
Government announces plans to increase funding for cancer treatment research and development.